Cargando…
Use of tetrasodium EDTA acid for the treatment of intraluminal obstruction of subcutaneous ureteral bypass devices
OBJECTIVES: The aim of this study was to evaluate the efficacy and tolerability of a 4% tetrasodium EDTA (tEDTA) infusion protocol in the subcutaneous ureteral bypass (SUB) devices of cats with intraluminal obstruction at a veterinary teaching hospital between July 2017 and April 2020. METHODS: This...
Autores principales: | Duval, Valerie, Dunn, Marilyn, Vachon, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511240/ https://www.ncbi.nlm.nih.gov/pubmed/35762269 http://dx.doi.org/10.1177/1098612X221107795 |
Ejemplares similares
-
Subcutaneous ureteral bypass device placement in 81 cats with benign ureteral obstruction (2013‐2018)
por: Wuillemin, Florian, et al.
Publicado: (2021) -
Therapeutic use of tetrasodium ethylenediaminetetraacetic acid solution for treatment of subcutaneous ureteral bypass device mineralization in cats
por: Chik, Colin, et al.
Publicado: (2019) -
Tetrasodium EDTA for the prevention of urinary catheter infections and blockages
por: Moore, Jessica V., et al.
Publicado: (2023) -
Multicenter retrospective evaluation of transmural migration of subcutaneous ureteral bypass devices within the digestive tract in cats
por: Véran, Emilie, et al.
Publicado: (2022) -
Subcutaneous pyelovesical bypass – Detour bypass – as a solution for ureteric obstruction
por: Wrona, Andrzej Jerzy, et al.
Publicado: (2017)